People living with #NASH / #MASH have historically felt unclear about a path to managing care. Kristin Bucklen, Vice President of Patient Marketing, elaborates on our approach to empowering individuals living with NASH/MASH to find a ‘way forward’ through education and engagement in a recent interview with Fierce Pharma: https://lnkd.in/eb6ygc4e
Madrigal Pharmaceuticals
制药业
Conshohocken,Pennsylvania 44,748 位关注者
Madrigal is focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases.
关于我们
Madrigal (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. For more information, visit www.madrigalpharma.com.
- 网站
-
https://www.madrigalpharma.com/
Madrigal Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Conshohocken,Pennsylvania
- 类型
- 上市公司
- 创立
- 2016
- 领域
- Liver Disease、NASH、Metabolic Disease和MASH
地点
-
主要
200 Barr-Harbor Dr
Suite 200
US,Pennsylvania,Conshohocken,19428
Madrigal Pharmaceuticals员工
动态
-
Join us for an engaging Product Theater at the Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) Seventh Annual Conference with speakers Ann Moore, FNP-C, Arizona Liver Health, and Jonathan 葉景湞 Yeh, PA, MBA, Columbia University Irving Medical Center, on September 12. View more details below.
-
We’re thrilled to celebrate a significant milestone at Madrigal, where more than 300 colleagues have joined us so far in 2024. Eight employees in 2016 has now grown to 500 team members! Welcome Khyati Oza Gosalia, our 500th colleague and a trained scientist with experience in project and alliance management. Khyati has lived as an expat in Korea and Vietnam and enjoys learning about different cultures, cooking, and spending time with her family and Australian labradoodle. She joins our expanding team of talented individuals, all dedicated to improving care for patients with NASH/MASH. Check out the Careers page to see our current openings: https://lnkd.in/eH9syce8
-
We’re excited to attend and connect with the #NASH / #MASH community at the 10th edition of the Paris MASH Meeting. #ParisMASH2024
-
Madrigal was thrilled to host a NASH/MASH Patient Advocacy Summit in Waltham, MA this week. We would like to thank all the attending patients and patient advocacy organizations for sharing your insights and ideas, and making this such a fun and productive meeting!?This was an invaluable opportunity for our team to listen, learn and think creatively about the future of NASH/MASH patient care. American Liver Foundation, Community Liver Alliance, Fatty Liver Alliance, Fatty Liver Foundation, Global Liver Institute, Mid South Liver Alliance (Teresa Davidson), NASH kNOWledge. Photo by Johnson Photography, Inc. - Boston Area
-
Just in time for the start of a new school year, the Clinical Practice Liaisons team dedicated part of their recent meeting to giving back to the community. The teammates filled backpacks with notebooks, pencils, rulers and other school supplies, which were donated to the Boys and Girls Clubs of Philadelphia. Click through for a look at their community service activity. #teambuilding #culture?
-
We’re heading to National Harbor, MD, September 12-14, for the Gastroenterology & Hepatology Advanced Practice Providers (#GHAPP) Seventh Annual Conference. Will you be there? Follow GHAPP for updates!?
The 2024 GHAPP National Conference is coming up next month! Join fellow APPs in Gastroenterology and Hepatology for a two-day event packed with professional development opportunities, the latest research, and valuable networking sessions. We look forward to seeing you there!
-
Today, we reported our Q2 #FinancialResults and provided corporate updates. We will host a conference call today at 8 am EDT. Learn more: https://bit.ly/4fOwCIn
-
Today, we announced the appointment of Shannon Kelley as General Counsel. Shannon has played an instrumental role guiding the company through a period of rapid growth and we look forward to her continued leadership. Learn more here: https://bit.ly/3SxUG8a
-
“For launch, we took a data-first approach, ultimately knowing that understanding our customers was imperative to our launch strategy.” Hear Gavin Dawson, Senior Director, Data Strategy and Analytics at Madrigal Pharmaceuticals, explain why they implemented a fully-integrated data foundation years ahead of launch to align stakeholders and commercialize with speed and precision. #biopharma #lifesciences #VeevaOpenData